We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Cogentix Medical, Inc. (NASDAQCM: CGNT) for $3.85 per share.
The investigation concerns whether the Board of Cogentix Medical breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether LABORIE Medical Technologies is underpaying for Cogentix Medical shares, thus unlawfully harming Cogentix Medical shareholders.
To receive more information, please fill out the form.